Prostate Specific Antigen in patients of benign prostate hypertrophy and carcinoma prostate

Indian Journal of Clinical Biochemistry

Volumn 21, Issue 1, 2006, Pages 34-40

  Malati, T ^a   Rajani Kumari, G ^a   Murthy, P V L N ^a   Ram Reddy, Ch ^a   Surya Prakash, B ^a  

^a NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

BPH; Carcinoma Prostate; Long term case study; Total PSA

Indexed keywords

BICALUTAMIDE; FLUTAMIDE; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CASE REPORT; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; EARLY CANCER; EARLY DIAGNOSIS; HEMATURIA; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NOCTURIA; ORCHIECTOMY; PHYSICAL EXAMINATION; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; ROC CURVE; SERUM; TRANSRECTAL ULTRASONOGRAPHY; TRANSURETHRAL RESECTION; URINARY FREQUENCY; URINARY TRACT INFECTION; URINARY TRACT OBSTRUCTION; URINE RETENTION;

EID: 33644925369     PISSN: 09701915     EISSN: 09701915     Source Type: Journal    
DOI: 10.1007/BF02913064     Document Type: Article

References (22)

1. Pienta and Esper (1993). Risk factors for prostate cancer. Ann Inter Med. 118, 793-803.
2. Morgan, T.O., Steven, J., Jacobsen, W.F., McCarthy, D.J., Jacobson, D.G., McLeod and Moul, J.W. (1996). Age Specific reference ranges for serum prostate specific Antigen in Black Men. New. Engl. J. Med. 335 (5), 304-310.
3. Kramer, B.S., Brown, M.L., Prorok, P.C., Potosky, A. and Gohagan, J.K. (1993). Prostate caner screening: what we know and what we need to know. Ann. Intern. Med. 119, 914-923.
4. Malati, T. and Rajani Kumari, G. (2004). Racial and Ethnic variation of Prostate Specific Antigen in global population: Age specific reference intervals for serum Prostate Specific Antigen in healthy South Indian males. Ind. J. Clin. Biochem. 19(1), 32-137.
5. Rajani Kumari, G. and Malati, T. (2004). Stability of total and free prostate specific antigen in serum samples at different storage conditions. Ind. J. Clin. Biochem. 19 (2), 10-13.
6. nd World Congress of Pathol. & Lab Medicine, Busan, Korea, Aug 30-Sept 3, 79-88.
7. Kuriyama, M., Wanf, M.C., Lee, C.L. et al. (1982) Multiple marker evaluation in prostate cancer with the use of tissue-specific antigen. JNCI. 69, 99-105.
8. Barak, M., Yoel, M., Aharon, L.JR and Nachran, G. (1989). Evaluation of prostate specific antigen as marker for adenocarcinoma of the prostate. J. Lab Clin. Med. 113 (5), 598-603.
9. Brawer, M.K. and Lange, P.H. (1989). Prostate-specific antigen: its role in early detection, staging and monitoring of prostatic carcinoma. J. Endo Urol. 3, 227.
10. Okihara, K., Cheli, C.D., Partin, A.W., Fritche, H.A., Chan, D.W., Sokoll, L.J., Brawer, M.K., Schwartz, M.K., Vessella, R.L., Loughlin, K.R., Johnston, D.A. and Babaian, R.J. (2002). Comparative analysis of complexed prostate specific antigen, free prostate specific antigen and their ratio in detecting prostate cancer. J. Urol. 167 (5), 2017-2023.
11. Lee, F., Trop Pedersen, S.T., Carroll, J.T., Siders, D.B., Christensson, D.C. and Mitchell, A.E. (1989). Use of transrectal ultrasound and prostate-specific antigen in diagnosis of prostatic intraepithelial neoplasm. Urology. 34, 4.
12. Partin, A.W., Carter, B.H., Chan, D.W., Jonathan, Estein, J.I., Oesterling, J.E., Rock, R.C., Weber, J.P. and Walch, P.C. (1990). Prostate specific antigen in the staging of localized prostate cancer: Influence of tumor differentiation, tumor volume and benign hyperplasia. J. Urol. 143, 747-752.
13. Stamey, T.A., Yang, N., Hay, AR., McNeal, J.E., Freiha, F.S. and Redwine, E. (1987). Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. New. Engl. J. Med. 317, 909-916.
14. Lange, P.H., Ercole, C.J., Lightner, D.J., Fraley, E.E. and Vessella, R. (1989). The value of serum prostate specific antigen determinations before and after radical prostatectomy. J. Urol. 141, 873-879.
15. Hudson, M.A., Bahnsen, R.R. and Catalona, W.J. (1989). Clinical use of prostate specific antigen in patients with prostate cancer. J. Urol. 151, 1291.
16. Monda, J.M., Barry, M.J. and Oesterling, J.E. (1994). Prostate-specific antigen can not distinguish stage T 1a (A1) from benign prostatic hyperplasia. J. Urol.142, 1011.
17. Wodrum, D.L., Brawer, M.K., Partin, A.W., Catalona, W.J. and Southwick, P.C. (1998). Interpretation of free prostate specific antigen clinical research studies for the detection of prostate cancer. J. Urol. 159, 5-12.
18. Myrtle, F. (1989). Normal levels of prostate-specific antigen (PSA). In: Clinical aspects of prostate cancer. (Eds) Catalona, W.J, Coffey, D.S. and Kaor, J.P. Elsevier Science Publishing Co., New York, p. 183-189.
19. Ercole, C.J., Lange, P.H., Mathsen, M., Chiou, R.K., Reddy, P.K. and Vessella, R.L. (1987). Prostate specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostate cancer. J. Urol. 138, 1181.
20. Cooner, W.H., Mosley, B.R., Rutherford, C.L., Jr., Beard, J.H., Pond, H.S., Terry, W.J., Igel, T.C. and Kidd, D.D. (1990). Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J. Urol.143, 1146.
21. Oesterling, J.E., Chan, D.W., Epstein, J.I., Kimball, A.W., Jr., Brujek, D.J., Rock, R.C., Brendler, C.B. and Walch, P.C. (1988). Prostate-specific antigen in the preoperative and postoperative evaluation of localized prostate cancer treated with radical prostatectomy. J. Urol. 139, 766.
22. Stamey, T.A., Kabalin, J.N. and Ferrori, M. (1989). Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. 1. Untreated patients. J. Urol. 141, 1070.